Anti-Anemia Drugs for People with Cancer or Kidney Failure Under FDA Scrutiny

Tagged:  

The article reports on the initiative of the U.S. Food and Drug Administration (FDA) to call a special meeting of its Oncologic Drugs Advisory Committee to review new data about anti-anemia drugs...

Share this with your friends
AttachmentSize
Anti-Anemia Drugs for People with Cancer or Kidney Failure Under FDA Scrutiny.pdf37.39 KB